This study is testing the long-term safety and effectiveness of the drug ALZ-801 in people with early Alzheimer's disease who have a specific genetic makeup (APOE4/4). It follows 163 participants for two years to see if the drug can help slow the decline in memory and thinking sk…
Phase: PHASE3 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC